Data as of Dec 12
| +0.07 / +3.00%|
The 4 analysts offering 12-month price forecasts for Pernix Therapeutics Holdings Inc have a median target of 2.50, with a high estimate of 5.00 and a low estimate of 2.00. The median estimate represents a +4.17% increase from the last price of 2.40.
The current consensus among 5 polled investment analysts is to Hold stock in Pernix Therapeutics Holdings Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.